{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:23Z","timestamp":1786982843904,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The clinical and hormonal overlap between neoplastic (CS) and non-neoplastic (NNH\/pCS) hypercortisolism is a challenge. Various dynamic tests have been proposed to allow an early discrimination between these conditions, but to date there is no agreement on which of them should be used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To provide an overview of the available tests and to obtain a quantitative synthesis of their diagnostic performance in discriminating NNH\/pCS from CS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The included articles, published between 1990 and 2022, applied one or more second line tests to differentiate NNH\/pCS from CS patients. For the NNH\/pCS group, we admitted the inclusion of patients presenting clinical features and\/or biochemical findings suggestive of hypercortisolism despite apparent lack of a pCS-related condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The electronic search identified 339 articles. After references analysis and study selection, we identified 9 studies on combined dexamethasone-corticotropin releasing hormone (Dex-CRH) test, 4 on Desmopressin test and 3 on CRH test; no study on Dex-Desmopressin met the inclusion criteria. Dex-CRH test provided the highest sensitivity (97%, 95 CI% [88%; 99%]). CRH tests showed excellent specificity (99%, 95% CI [0%; 100%]), with low sensitivity. Although metaregression analysis based on diagnostic odds ratio failed to provide a gold standard, CRH test (64.77, 95% CI [0.15; 27,174.73]) seemed to lack in performance compared to the others (Dex-CRH 138.83, 95% CI [49.38; 390.32] and Desmopressin 110.44, 95% CI [32.13; 379.63]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Both Dex-CRH and Desmopressin tests can be valid tools in helping discrimination between NNH\/pCS and CS. Further studies are needed on this topic, possibly focusing on mild Cushing\u2019s Disease and well-characterized NNH\/pCS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022359774\">https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022359774<\/jats:ext-link>\n                      , identifier CRD42022359774.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-023-02099-z","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:42:41Z","timestamp":1682001761000},"page":"1947-1959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-5198","authenticated-orcid":false,"given":"A.","family":"Mondin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-5727","authenticated-orcid":false,"given":"M.","family":"Barbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3628-0492","authenticated-orcid":false,"given":"G.","family":"Voltan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-5107","authenticated-orcid":false,"given":"I.","family":"Tizianel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. K.","family":"Vedolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-1652","authenticated-orcid":false,"given":"M.","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-3815","authenticated-orcid":false,"given":"C.","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1456-8716","authenticated-orcid":false,"given":"F.","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"5","key":"2099_CR1","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/EJE-16-0946","volume":"176","author":"JW Findling","year":"2017","unstructured":"Findling JW, Raff H, Diagnosis of Endocrine Disease (2017) Differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome. Eur J Endocrinol 176(5):R205\u2013R216. https:\/\/doi.org\/10.1530\/EJE-16-0946","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2099_CR2","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EC-19-0435","volume":"9","author":"C Scaroni","year":"2020","unstructured":"Scaroni C, Albiger NM, Palmieri S et al (2020) Approach to patients with pseudo-Cushing\u2019s states. Endocr Connect 9(1):R1\u2013R13. https:\/\/doi.org\/10.1530\/EC-19-0435","journal-title":"Endocr Connect"},{"issue":"5","key":"2099_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2099_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2099_CR5","doi-asserted-by":"publisher","first-page":"101519","DOI":"10.1016\/j.beem.2021.101519","volume":"35","author":"S Petersenn","year":"2021","unstructured":"Petersenn S (2021) Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing. Best Pract Res Clin Endocrinol Metab 35(1):101519. https:\/\/doi.org\/10.1016\/j.beem.2021.101519","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"2099_CR6","doi-asserted-by":"publisher","first-page":"dgaa105","DOI":"10.1210\/clinem\/dgaa105","volume":"105","author":"BP Galm","year":"2020","unstructured":"Galm BP, Qiao N, Klibanski A, Biller BMK, Tritos NA (2020) Accuracy of laboratory tests for the diagnosis of cushing syndrome. J Clin Endocrinol Metab 105(6):dgaa105. https:\/\/doi.org\/10.1210\/clinem\/dgaa105","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2099_CR7","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/jama.1993.03500170062035","volume":"269","author":"JA Yanovski","year":"1993","unstructured":"Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK (1993) Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states. JAMA 269(17):2232\u20132238","journal-title":"JAMA"},{"issue":"5","key":"2099_CR8","doi-asserted-by":"publisher","first-page":"R201","DOI":"10.1530\/EJE-18-0007","volume":"178","author":"DA Vassiliadi","year":"2018","unstructured":"Vassiliadi DA, Tsagarakis S (2018) Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing\u2019s syndrome. Eur J Endocrinol 178(5):R201\u2013R214. https:\/\/doi.org\/10.1530\/EJE-18-0007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2099_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s11102-017-0824-8","volume":"20","author":"AV Araya","year":"2017","unstructured":"Araya AV, Romero C, Lemp M (2017) Combined dexamethasone and desmopressin test in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome and pseudo-cushing\u2019s states. Pituitary 20(5):602\u2013603. https:\/\/doi.org\/10.1007\/s11102-017-0824-8","journal-title":"Pituitary"},{"key":"2099_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16","journal-title":"BMC Med Inform Decis Mak"},{"issue":"4","key":"2099_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD et al (2018) Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement [published correction appears in JAMA. 2019 Nov 26;322(20):2026]. JAMA 319(4):388\u2013396","journal-title":"JAMA"},{"issue":"8","key":"2099_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"2099_CR13","unstructured":"Ceccato F. Second line tests in the differential diagnosis of neoplastic and functional hypercortisolism: a systematic review and meta-analysis. https:\/\/researchdata.cab.unipd.it\/id\/eprint\/827 2023. Repository data of the University of Padova. Date of deposit 02 February 2023"},{"issue":"7","key":"2099_CR14","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1210\/jc.2005-2143","volume":"91","author":"NM Martin","year":"2006","unstructured":"Martin NM, Dhillo WS, Banerjee A et al (2006) Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing\u2019s syndrome. J Clin Endocrinol Metab 91(7):2582\u20132586","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2099_CR15","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1210\/jc.2006-2829","volume":"92","author":"B Gatta","year":"2007","unstructured":"Gatta B, Chabre O, Cortet C et al (2007) Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing\u2019s disease from pseudo-Cushing\u2019s syndrome. J Clin Endocrinol Metab 92(11):4290\u20134293. https:\/\/doi.org\/10.1210\/jc.2006-2829","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2099_CR16","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1210\/jc.2006-2662","volume":"92","author":"D Erickson","year":"2007","unstructured":"Erickson D, Natt N, Nippoldt T et al (2007) Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab 92(8):2972\u20132976. https:\/\/doi.org\/10.1210\/jc.2006-2662","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2099_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-2265.2006.02717","volume":"66","author":"F Pecori Giraldi","year":"2007","unstructured":"Pecori Giraldi F, Pivonello R, Ambrogio AG et al (2007) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states [published correction appears in Clin Endocrinol (Oxf). 2007 Sep;67(3):477]. Clin Endocrinol (Oxf) 66(2):251\u2013257. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02717","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2099_CR18","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1210\/jc.2008-0985","volume":"93","author":"DL Batista","year":"2008","unstructured":"Batista DL, Courcoutsakis N, Riar J, Keil MF, Stratakis CA (2008) Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome. J Clin Endocrinol Metab 93(11):4323\u20134330. https:\/\/doi.org\/10.1210\/jc.2008-0985","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2099_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/EJE-08-0402","volume":"159","author":"G Reimondo","year":"2008","unstructured":"Reimondo G, Bovio S, Allasino B et al (2008) The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing\u2019s syndrome. Eur J Endocrinol 159(5):569\u2013576. https:\/\/doi.org\/10.1530\/EJE-08-0402","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2099_CR20","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1210\/jc.2009-1500","volume":"94","author":"E Valassi","year":"2009","unstructured":"Valassi E, Swearingen B, Lee H et al (2009) Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing\u2019s syndrome. J Clin Endocrinol Metab 94(12):4851\u20134859. https:\/\/doi.org\/10.1210\/jc.2009-1500","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2099_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-13-0702","volume":"170","author":"RA Alwani","year":"2014","unstructured":"Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA (2014) Differentiating between Cushing\u2019s disease and pseudo-Cushing\u2019s syndrome: comparison of four tests. Eur J Endocrinol 170(4):477\u2013486. https:\/\/doi.org\/10.1530\/EJE-13-0702","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2099_CR22","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1210\/jcem.85.10.6862","volume":"85","author":"M Moro","year":"2000","unstructured":"Moro M, Putignano P, Losa M, Invitti C, Maraschini C, Cavagnini F (2000) The desmopressin test in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing states. J Clin Endocrinol Metab 85(10):3569\u20133574. https:\/\/doi.org\/10.1210\/jcem.85.10.6862","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2099_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1210\/jc.2009-1146","volume":"95","author":"G Tirabassi","year":"2010","unstructured":"Tirabassi G, Faloia E, Papa R, Furlani G, Boscaro M, Arnaldi G (2010) Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing\u2019s disease. J Clin Endocrinol Metab 95(3):1115\u20131122. https:\/\/doi.org\/10.1210\/jc.2009-1146","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2099_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/cen.12661","volume":"82","author":"GA Rollin","year":"2015","unstructured":"Rollin GA, Costenaro F, Gerchman F, Rodrigues TC, Czepielewski MA (2015) Evaluation of the DDAVP test in the diagnosis of Cushing\u2019s Disease. Clin Endocrinol (Oxf) 82(6):793\u2013800. https:\/\/doi.org\/10.1111\/cen.12661","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2099_CR25","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2265.2011.04096.x","volume":"75","author":"G Tirabassi","year":"2011","unstructured":"Tirabassi G, Papa R, Faloia E, Boscaro M, Arnaldi G (2011) Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state: a comparative study. Clin Endocrinol (Oxf) 75(5):666\u2013672. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04096.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2099_CR26","doi-asserted-by":"publisher","first-page":"dgaa564","DOI":"10.1210\/clinem\/dgaa564","volume":"105","author":"F Ceccato","year":"2020","unstructured":"Ceccato F, Tizianel I, Vedolin CK, Boscaro M, Barbot M, Scaroni C (2020) Human corticotropin-releasing hormone tests: 10 years of real-life experience in pituitary and adrenal disease. J Clin Endocrinol Metab 105(11):dgaa564. https:\/\/doi.org\/10.1210\/clinem\/dgaa564","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2099_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1530\/EJE-10-1120","volume":"164","author":"HL Storr","year":"2011","unstructured":"Storr HL, Alexandraki KI, Martin L et al (2011) Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing\u2019s disease. Eur J Endocrinol 164(5):667\u2013674. https:\/\/doi.org\/10.1530\/EJE-10-1120","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2099_CR28","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1210\/jc.2007-1289","volume":"92","author":"L Nieman","year":"2007","unstructured":"Nieman L (2007) Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing\u2019s syndrome: what have we learned in 14 years? J Clin Endocrinol Metab 92(8):2876\u20132878. https:\/\/doi.org\/10.1210\/jc.2007-1289","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2099_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","volume":"43","author":"F Ceccato","year":"2020","unstructured":"Ceccato F, Artusi C, Barbot M et al (2020) Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J Endocrinol Invest 43(8):1105\u20131113. https:\/\/doi.org\/10.1007\/s40618-020-01197-6","journal-title":"J Endocrinol Invest"},{"key":"2099_CR30","unstructured":"Ferring\u2014CRH GHRH. Published 2022. https:\/\/www.ese-hormones.org\/media\/4911\/ferring-pharmaceuticals-response-crh-ghrh-december-2022.pdf. Accessed 30 Jan 2023"},{"issue":"6","key":"2099_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3343\/alm.2021.41.6.521","volume":"41","author":"S Pinelli","year":"2021","unstructured":"Pinelli S, Barbot M, Scaroni C, Ceccato F (2021) Second-line tests in the diagnosis of adrenocorticotropic hormone-dependent hypercortisolism. Ann Lab Med 41(6):521\u2013531. https:\/\/doi.org\/10.3343\/alm.2021.41.6.521","journal-title":"Ann Lab Med"},{"key":"2099_CR32","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org\/handbook."},{"issue":"10","key":"2099_CR33","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2015-2507","volume":"100","author":"F Ceccato","year":"2015","unstructured":"Ceccato F, Barbot M, Zilio M et al (2015) Screening tests for cushing\u2019s syndrome: urinary free cortisol role measured by LC-MS\/MS. J Clin Endocrinol Metab 100(10):3856\u20133861. https:\/\/doi.org\/10.1210\/jc.2015-2507","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt B","key":"2099_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cca.2015.10.004","volume":"451","author":"G Antonelli","year":"2015","unstructured":"Antonelli G, Ceccato F, Artusi C, Marinova M, Plebani M (2015) Salivary cortisol and cortisone by LC-MS\/MS: validation, reference intervals and diagnostic accuracy in Cushing\u2019s syndrome. Clin Chim Acta 451(Pt B):247\u2013251. https:\/\/doi.org\/10.1016\/j.cca.2015.10.004","journal-title":"Clin Chim Acta"},{"issue":"8","key":"2099_CR35","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","volume":"107","author":"P Limumpornpetch","year":"2022","unstructured":"Limumpornpetch P, Morgan AW, Tiganescu A et al (2022) The effect of endogenous cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab 107(8):2377\u20132388. https:\/\/doi.org\/10.1210\/clinem\/dgac265","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2099_CR36","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s40618-021-01615-3","volume":"44","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Barbot M, Scaroni C, Boscaro M (2021) Frequently asked questions and answers (if any) in patients with adrenal incidentaloma. J Endocrinol Invest 44(12):2749\u20132763. https:\/\/doi.org\/10.1007\/s40618-021-01615-3","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2099_CR37","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s40618-021-01539-y","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M, Robles L\u00e1zaro C, Parra Ram\u00edrez P et al (2021) Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas. J Endocrinol Invest 44(11):2349\u20132357. https:\/\/doi.org\/10.1007\/s40618-021-01539-y","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02099-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T22:16:42Z","timestamp":1695334602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02099-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02099-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest that might be perceived as influencing the impartiality of the reported research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study does not require informed consent, because it is a review, therefore it is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}